SAMPRE NUTRITIONS LTD.

Sampre Nutritions Limited has received in-principle approval from the BSE for the issuance and allotment of 1,770,710 equity shares of INR 5 each at a price of not less than INR 42 each. These shares will be issued to the promoter and promoter group on a preferential basis, converting unsecured loans aggregating to INR 7,43,69,820. The company has been advised to strengthen internal controls and obtain undertakings from allottees regarding trading restrictions to ensure compliance with SEBI regulations.

Sampre Nutritions Ltd has informed the stock exchanges about dispatching letters to shareholders holding shares in physical form. These letters contain a QR code providing direct access to the Annual Report for the financial year 2025-26 and the Notice of the 35th Annual General Meeting (AGM). This measure is in compliance with SEBI Listing Regulations for shareholders whose email addresses are not registered. The AGM is scheduled for September 4, 2026. Shareholders are also reminded to update KYC details and consider dematerializing physical shares as per SEBI's recent circular.

Sampre Nutritions Ltd has issued a corrigendum to the notice of its 35th Annual General Meeting (AGM). The corrigendum rectifies a typographical error concerning the date of appointment of the scrutinizer. The company states that this error was purely typographical and did not affect the substance of the AGM notice, proposed resolutions, or the Annual Report. The corrected Annual Report has been dispatched to members and uploaded on the company's website. The 35th AGM is scheduled for September 4, 2026, to be held via Video Conferencing.

Sampre Nutritions Ltd has announced its 35th Annual General Meeting (AGM) scheduled for September 4, 2026, at 11:00 AM IST, to be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has also released its Annual Report for the financial year 2025-26. The intimation for both the annual report and the AGM notice was disseminated on August 10, 2026. The annual report is being circulated electronically to members with registered email addresses and via web link to others. The report includes details on the Board of Directors, statutory committees, key managerial personnel, auditors, bankers, and registrar and share transfer agents.

Sampre Nutritions Ltd has announced its 35th Annual General Meeting (AGM) will be held on Friday, September 4, 2026, at 11:00 AM IST. The meeting will be conducted virtually through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company will also share its Annual Report for the financial year 2025-26 with its members. Key agenda items include adopting the audited financial statements for FY26, reappointing Vishal Ratan Gurbani as Director, and approving a significant revision in his remuneration from ₹18,00,000 to ₹60,00,000 per annum, effective April 1, 2026. The cut-off date for remote e-voting is August 28, 2026, with the e-voting period commencing on September 1 and concluding on September 3, 2026.

Sampre Nutritions Limited has announced a Board of Directors meeting scheduled for August 5, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. Additionally, the board will decide on the date, time, and venue for the 35th Annual General Meeting (AGM) and approve its notice. A significant proposal to increase the annual remuneration of Vishal Gurbani, Whole-Time Director, from INR 18,00,000 to INR 60,00,000, effective April 1, 2026, subject to member approval at the AGM, will also be discussed.

Sampre Nutritions Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI regulations and the company's code of conduct, specifically for the announcement of unaudited standalone and consolidated financial results for the first quarter of the financial year 2026-27, ending on June 30, 2026. The trading window will remain shut from July 1, 2026, until 48 hours after the declaration of these financial results. The exact date of the Board of Directors' meeting to approve these results will be communicated later. Promoters, directors, designated persons, and their immediate relatives are prohibited from trading during this period.

Sampre Nutritions Ltd. has issued a commemorative communication acknowledging approximately 30 years of business association with a customer entity. This disclosure, made under Regulation 30 of the SEBI (LODR) Regulations, 2015, is intended for transparency and dissemination of information to stakeholders. The company clarifies that this does not relate to any new contract, order, agreement, or strategic partnership, nor does it involve any financial commitment or modification of existing commercial terms. The disclosure is voluntary and should not be construed as an advertisement or endorsement.

Sampre Nutritions Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.

Sampre Nutritions Ltd has announced the closure of the trading window for the fourth quarter and financial year 2025-26. The closure will commence on 1 April 2026 and will last until 48 hours after the declaration of audited financial results. The decision is in accordance with Regulation 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the Company’s Code of Conduct. Promoters, directors, designated persons, specific connected persons, and their immediate relatives are advised not to trade in securities of the Company during this period.